Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 12.91
-0.19 (-1.45%)
Sep 2, 2026, 1:19 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.31 billion as of September 1, 2026. Its market cap has decreased by -10.46% in one year.
Market Cap
3.31B
Enterprise Value
3.62B
Revenue
1.42B
Ranking
n/a
PE Ratio
41.14
Stock Price
12.91
ChartMarket Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.31B, an increase of 46.09%. That is a compound annual growth rate of 5.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.31B | -7.42% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.53B |
| Jiangsu Bioperfectus Technologies | 3.52B |
| Lifecome Biochemistry | 3.41B |
| Shanghai Shen Lian Biomedical | 3.36B |
| Hinova Pharmaceuticals | 3.35B |
| Guanhao Biotech | 3.18B |
| Baolingbao Biology | 3.11B |
| Beijing Kawin Technology Share-Holding | 3.06B |